GlassScriptPhysician profile
Jennifer Canan
NPI 1871931410
$2,163.27
in general payments reported to CMS, 2019-2025
24 companies · $46.76 in 2025
The $46.76 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $495 · 2020: $213 · 2021: $641 · 2022: $226 · 2023: $337 · 2024: $204 · 2025: $46.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $400 · Education: $188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $400.29 |
| Education | $187.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $558.13 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Astellas Pharma US INC | $230.33 | 2023-2024 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $229.22 | 2019-2024 | Thinprep 2000 Processor, Aptima, Novasure |
| Mayne Pharma Commercial LLC | $170.31 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $155.41 | 2019-2025 | |
| Avion Pharmaceuticals | $116.73 | 2021-2022 | |
| Therapeuticsmd, INC. | $88.34 | 2019-2021 | |
| Daiichi Sankyo INC. | $87.50 | 2020-2023 | Injectafer |
| Ethicon US, LLC | $69.01 | 2019-2024 | Harmonic |
| Pfizer INC. | $66.96 | 2020-2022 | |
| Novo Nordisk INC | $59.76 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $59.21 | 2023-2024 | Myfembree, Gemtesa |
| Exact Sciences Corporation | $50.74 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Sage Therapeutics, LLC | $44.02 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $29.59 | 2019-2023 | Gardasil 9 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $23.22 | 2020 | |
| Myovant Sciences INC. | $21.80 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.86 | 2023 | Lifevest |
| Allergan, INC. | $15.72 | 2019 | |
| Exeltis, USA INC. | $15.54 | 2023 | Slynd |
| Meditrina | $13.84 | 2025 | |
| Avanos Medical | $13.75 | 2021 | |
| Dysis Medical, INC. | $13.11 | 2021 | |
| Currax Pharmaceuticals LLC | $11.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Canan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.